Conference abstractPublished 20 Sep 2018
Zn(II)/Au(I), Zn(II)/Ag(I), Cu(II) and Co(II) complexes with Schiff bases as promising cytotoxic agents: is there a room for optimism
Bulgarian Academy of Sciences, Bulgaria
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The aim of our study was to evaluate the cytotoxic activity of the following compounds: six complexes of Zn(II)/Au(I) and Zn(II)/Ag(I) with Salen, Salampy and Salampy and eight complexes of Cu(II) and Co(II) with Schiff bases derived by a condensation reaction of о-Vanillin with S-Tyrosine, L-Threonine, DL-Tryptophan or L-Serine. As model systems were used six permanent cell lines: MCF-7 and MDA-MB-231 (human breast cancer); HeLa (human cervical carcinoma); LACC-SF-Mc29 (chicken hepatoma); LSR-SF-SR (rat sarcoma) and Lep-3 (non-tumor human embryonic fibroblastoid cells). The investigations were performed by MTT test, neutral red uptake cytotoxicity assay, crystal violet staining, double staining with propidium iodide and acridine orange, Comet assay, Annexin V – FITC test (in short-term experiments, 3-72h, with monolayer cultures) and colony-forming method (in long-term experiments, 30-40 days, with 3D cell colonies). The compounds were examined in ROS generating systems, DPPH test was also performed. Our results indicate that the complexes investigated decrease viability and proliferation of the treated cells in a time- and concentration-dependent manner. The most pronounced cytotoxic agents are Zn(II)/Au(I) complexes with Salen, Salampy and Saldmen (active in the concentration range 0.05 - 5 µg/ml), followed by Zn(II)/Ag(I) complexes of the same ligands (active in the concentration range 1-20 µg/ml). The CC50 of Zn(II)/Au(I) and Zn(II)/Ag(I) complexes are lower than those of cisplatin. Cu(II) complexes are effective applied at concentrations of 10-200 µg/ml. Co(II) complexes show the lowest rate of cytotoxicity (active in a concentration range 50 - 400 µg/ml). Cu(II) and Co(II) complexes do not express antioxidant activity.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Radostina Alexandrova”